Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)
7.57 x 2 7.60 x 2
Post-market by (Cboe BZX)
7.56 -0.13 (-1.69%) 03/25/25 [NASDAQ]
7.57 x 2 7.60 x 2
Post-market 7.58 +0.02 (+0.26%) 19:37 ET
Quote Overview for Tue, Mar 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.48
Day High
7.72
Open 7.68
Previous Close 7.69 7.69
Volume 2,265,400 2,265,400
Avg Vol 4,265,655 4,265,655
Stochastic %K 18.31% 18.31%
Weighted Alpha -16.51 -16.51
5-Day Change -0.39 (-4.91%) -0.39 (-4.91%)
52-Week Range 3.81 - 23.86 3.81 - 23.86
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,236,890
  • Shares Outstanding, K 160,844
  • Annual Sales, $ 682,160 K
  • Annual Income, $ -187,500 K
  • EBIT $ -249 M
  • EBITDA $ -200 M
  • 60-Month Beta 2.92
  • Price/Sales 1.79
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 67.82% ( +1.16%)
  • Historical Volatility 68.93%
  • IV Percentile 1%
  • IV Rank 2.20%
  • IV High 187.27% on 05/13/24
  • IV Low 65.13% on 05/09/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 8,113
  • Volume Avg (30-Day) 10,803
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 242,635
  • Open Int (30-Day) 244,385

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.43
  • Number of Estimates 4
  • High Estimate -0.26
  • Low Estimate -0.58
  • Prior Year -1.05
  • Growth Rate Est. (year over year) +59.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.02 +7.69%
on 02/27/25
Period Open: 7.17
8.63 -12.40%
on 03/03/25
+0.39 (+5.44%)
since 02/25/25
3-Month
7.02 +7.69%
on 02/27/25
Period Open: 8.51
11.55 -34.55%
on 01/07/25
-0.95 (-11.16%)
since 12/24/24
52-Week
3.81 +98.43%
on 04/18/24
Period Open: 4.81
23.86 -68.32%
on 06/06/24
+2.75 (+57.17%)
since 03/25/24

Most Recent Stories

More News
Moderna Stock: Is MRNA Underperforming the Healthcare Sector?

As Moderna has underperformed its broader sector recently, analysts remain cautious about the stock’s prospects.

XLV : 145.27 (-1.28%)
NVAX : 7.56 (-1.69%)
MRNA : 33.85 (-0.94%)
PFE : 25.55 (-2.26%)
BNTX : 97.05 (-3.57%)
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying

Buying stocks after they have lost significant market value can lead to excellent returns in the long run, but only if the company in question can reverse its fortunes.

TLRY : 0.6816 (-0.10%)
NVAX : 7.56 (-1.69%)
1 Biotech Stock to Buy in 2025, and 1 to Avoid

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year. Both companies saw their shares rise significantly; the former had exciting...

VKTX : 27.98 (-4.44%)
NVAX : 7.56 (-1.69%)
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership

The company expects to generate $300 million to $350 million in adjusted licensing, royalties, and other revenue in 2025.

NVAX : 7.56 (-1.69%)
SNY : 55.45 (-0.86%)
Novavax: Q4 Earnings Snapshot

Novavax: Q4 Earnings Snapshot

NVAX : 7.56 (-1.69%)
Novavax Retail Traders Stay Bullish Ahead Of Q4 Print Even As RFK Jr's HHS Leadership Causes Ripples

Kennedy, a longtime vaccine skeptic, now oversees HHS decisions that could impact vaccine makers, making his leadership a wild card for Novavax.

NVAX : 7.56 (-1.69%)
SNY : 55.45 (-0.86%)
New Strong Buy Stocks for January 28th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Potbelly Corporation PBPB: This franchise company has seen the Zacks Consensus Estimate for its current year earnings increasing...

PBPB : 9.50 (-2.86%)
BBCP : 5.17 (-7.01%)
NVAX : 7.56 (-1.69%)
BAK : 3.69 (+1.65%)
ETON : 13.74 (-7.10%)
We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued

Message volume on Stocktwits has surged by over 1,200% since the beginning of the year, reflecting growing interest.

IBB : 132.97 (-1.73%)
NVAX : 7.56 (-1.69%)
XBI : 87.08 (-1.96%)
IWM : 207.70 (-0.56%)
SNY : 55.45 (-0.86%)
Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0

While vaccine-related investments have broadly suffered following Trump’s electoral victory, NVAX stock may represent a compelling compromise.

NVAX : 7.56 (-1.69%)
PFE : 25.55 (-2.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple...

See More

Key Turning Points

3rd Resistance Point 7.93
2nd Resistance Point 7.82
1st Resistance Point 7.69
Last Price 7.56
1st Support Level 7.45
2nd Support Level 7.35
3rd Support Level 7.22

See More

52-Week High 23.86
Fibonacci 61.8% 16.20
Fibonacci 50% 13.83
Fibonacci 38.2% 11.47
Last Price 7.56
52-Week Low 3.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals